However, these technical issues should have affected the samples randomly and thus alone, cannot explain the significant differences in the extent of KCNB1 oxidation, protein carbonylation, FAK and Src phosphorylation and GFAP immunoreactivity that exist between control and AD brains. Here, GFAP is linked to Alzheimer disease.